Health ❯Pharmacology

Drug Development

Clinical Trials Natural Compounds Therapeutics Cancer Treatments Repurposing Drugs Compound Screening Research and Development Opioid Receptors Biological Agents Opioid Withdrawal

Membrane Lipid Drives Biased Signaling in 5-HT1A Serotonin Receptor

Researchers at Mount Sinai plan to validate their molecular findings in complex models before designing targeted antidepressant candidates.

Deep-Sea Bacterial Molecule Triggers Pyroptosis to Suppress Tumor Growth

NSAIDs Strengthen Gut’s Parasite-Fighting Immune Pathway

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia

Benzaldehyde Disrupts Protein Interface to Thwart Pancreatic Cancer Resistance and Metastasis

Ambroxol Demonstrates Safety and Neuroprotection Signals in Parkinson’s Dementia Trial

PDE3 Inhibitors Stimulate Bone Growth in Mice, Offering Potential for Skeletal Disorder Therapies

Researchers Seek Synthetic Route for Sea Cucumber Compound That Blocks Cancer Enzyme

Ibudilast Fails in Alcohol Use Disorder Trial, Curbs Drinking Among Women

HIV Drugs Linked to Lower Alzheimer’s Risk, Prompting Calls for Clinical Trials

Researchers Advance TYK2 Inhibitor Toward Type 1 Diabetes Clinical Trials

UBC Patents Gut-Targeted Drug Delivery System with Reduced Side Effects

Study Links Estrogen to Increased Binge Drinking in Females

Brain Enzyme Inhibition Shows Promise for Obesity Treatment

New Oral Drug Targets Chronic Abdominal Pain with Oxytocin-Based Approach

Caterpillar Fungus Compound Shows Promise in Slowing Cancer Cell Growth

Caterpillar Fungus Shows Promise in Cancer Treatment

Antidepressant Vortioxetine Shows Potential in Treating Aggressive Brain Tumors

Advanced Mapping of GPCR Interactions Revolutionizes Drug Discovery

Cancer Drug Shows Promise in Treating Early-Stage Alzheimer’s